Pharma Marketing Blog represents the opinions of
John Mack
Publisher of
Pharma Marketing News.
We accept advertising relevant to the interests of our members.
For more information, see:
Operated by:
VirSci Corporation
PO Box 760
Newtown, PA 18940
215-504-4164
215-504-5739 (FAX)
E-mail: infovirsci@virsci.com
| Blog Topics in this Category | All Pharma Marketing Blog Topics |
If you wish to receive notice by email whenever a post is made to Pharma Marketing Blog, please subscribe.
The following Pharma Marketing Blog topics focus on the pharmaceutical industry's reputation and PR efforts to improve the perception of the industry in the public's eye. Posts are listed in reverse chronological order:
- Vytorin Ads Trump Peter Rost on Fox Business News
- Overcoming Pharma's Employee Blogging Fears
- Centocor Blog - No Frying Pan and No Fire!
- CNTO411: Centocor's Groundbreaking Blog
- Jarvik: A Modern DTC Tragedy
- Pfizer Flips. Jarvik Flops!
- Pharma R&D Succumbs to the Dark Side
- Montel Says Goodbye to TV! May Leave PhRMA's PPA Program Also
- Jarvik Falters in His Own Defense
- Different Views of Pharma and its Critics
- Should I Stop Taking Zetia?
- Rozerem Deep Sea Diver Debuts in New Yorker Cartoon Contest
- Jarvik -- Lipitor spokesperson -- "outed" as an unlicensed physician!
- Promotion vs. R&Deja vu all over again!
- Giuliani's OxyContin (and PhRMA) Money
- PGAD. EGAD! Another Syndrome/Disorder, Whatever!
- Montel Williams Seeks Interns for 2008 - I Kid You Not!
- PhRMA Intern v. Montel: HS Intern is Saved, But...
- Montel Williams: Zero Tolerance for a Pharma Celebrity Spokesperson Gone Bad
- J&J Blog, Shire PR: The Whole Story and Nothing But the Whole Story!
- Rozerem Expedites Experts' Dreams: Honoraria!
- J&J Lawyers Go Wild; PR on Vacation!
- The Drug Advertising Blame Game
- Mandatory Vaccination Controversy Did Not Hurt Gardasil Sales!
- The "RLS Gene" Story: Requip Ad Disguised as News on ABC
- Advice to All Pharma PR Bloggers Out There
- Moore's Blitzer Krieg
- The Drug Industry Needs Constructive Criticism, Not Pugilistic Put Downs
- It Was Politics That Killed Avandia, Says Glaxo
- PhRMA Intern Makes Movie Mogul an Offer He Can't Refuse!
- Cause Marketing via YouTube: What Pharma Can Learn from Michael Moore
- PhRMA Sent SiCKO Spy to Cannes
- SiCKO is Boffo but Not Anti-Pharmaco, per se
- Moore, Oprah, SiCKO: The Video
- Pharma's Worst Fear Realized: After Seeing SiCKO Oprah Calls for Town Hall Meeting
- GSK's YouTube Disease Awareness Sponsorship
- Alli Ad Campaign Promises Honesty, But Does It Deliver?
- Advice to GSK on Handling the Avandia Avalanche: Don't Do What Merck Did
- Mr. Moore Don't Ignore: Please Invite Me to a Screening of Your Movie
- Giuliani, OxyContin, Big Pharma, and Terrorism
- Gardasil: Less Hype May Help
- Pfizer's Exubera Strategy Needs a Bong Blog!
- J&J to Give 120,000 Employees Their Own Blogs?
- Americans Skeptical Of Pharma Cause Marketing
- Lilly Cuts PAP and Runs from Patients in Need, Putting Profits First
- Pharma Still Stinks, But Not as Much as Oil or Tobacco!
- GSK Pulls Imus Ads...BUT, Only Until "Media Standards" Are Met
- Glaxo, Pull Your Imus Ads!
- A Few Rules for Pharma Employee Blogging
- The Zubillaga Affair: Effect on the Prospects for Pharma Blogging
- Web 2.0 Hates Sally
- Dead DTC Golden Goose and Other Pharma Fears
- Innerstate Private Screening: Philadelphia Style
- Drug Safety - A Mere Asterisk to the FDA
- Does Merck Need a Vaccine for Bad PR?
- No Oscar for Centocor PR Effort
- Who's Easier to Buy? A Physician or a Politician?
- Merck Quits Lobbying for Mandatory Gardasil Vaccination
- Marketing Drugs to Teens Online - So Wrong!
- PhRMA Responds to My Rozerem Ad "Concern"
- God Bless R&D, but Marketers May Go to Hell!
- GSK: Don't Go Cold Turkey!
- Takeda: It Isn't a Reminder Ad --- Wha!!!
- If Bill Gates Ran Pharma
- Disease Mongering and Pharma Credibility
- Introducing...the All-Pharma Lobbying Lineup!
- If FDA were as Powerful as FTC
- YouPharma(tm): A Brave New World of Marketing?
- DTC in the New Era
- What Was Blogworthy in 2006? A Review
- Merck on a Roll
- Is Pfizer Arrogant and Superior?
- Am I Dreaming, or Is This a Rozerem Ad?
- Levitra Levity
- Do New Drugs Prolong Lives?
- Clear Words, Obscure Benefits
- Rozerem Ads Innovatively Ineffectual
- Pharma's Black Knight Parties On!
- Confusing Creativity with Mission
- Sicko si, Pharmaco no!?
- Anonymous Online Marketing
- Rules of Engagement
- PhRMA Intern vs. the Pharma PR Agency!
- DTC Menagerie & Bad Buzz
- Question Everything
- DTC, Elections, and PhRMA
- PhRMA's Response - PRwise, it Stinks!
- Chantix: PR First, Launch & Ads to Follow
- PR Marketing: Mystery Wrapped in a Riddle
- Marketing Disguised as PR
- Industry PR & Rep Morale
- Doing a Good Job but Still No Respect!
- Pharma and Republicans Part Ways
- Pharma Industry "Less Unpopular"
- How Not to Influence Physician Bloggers
- Spinning Bad News about FDA & Drug Safety
- GSK's "Plain Talk" Flawed
- Pharma PR: It's All About Defending Drug Prices
- Sales Reps Make Poor Spokespeople
- Michael Moore Seeks "Sickos"
- Challenges Ahead for Pharma
- Finally, Marketing Aligns with PR - Maybe
- 2006 Pharma Trend Survey
- Pfizer - the Rodney Dangerfield of the Drug Industry
- New Year's Resolutions for Pharma
- Less DTC, Better Public Image?
- J&J Scores High in Reputation Quotient Study
- Tobacco & Drugs: Strange Bedfellows
- The Empire Strikes Back
- Vagelos Speaks. Will Pharma Listen?
- Pharma Industry's Relief Effort
- Pharma Image Makeover Tactics Unconvincing
- Movies and Drugs: Same Blockbuster Mentality
- Bloggers Worry Pharma More Than FDA
- McKinnell's Mea Non Culpa
- Transparency: A New Voice for Pharma
- Can't Get Any Respect!
- Peter Rost: Pharma's Black Knight
- Patients Come First?
- Drug Companies Give Aid to Tsunami Victims
- The Pharma Industry Has Issues in 2005
- Pharmaceutical PR: Fool Me Once, Fool Me Twice